HilleVax, Inc. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
HilleVax, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q2 2024.
- HilleVax, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$43M, a 42.3% decline year-over-year.
- HilleVax, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$167M, a 66.7% decline year-over-year.
- HilleVax, Inc. annual Operating Income (Loss) for 2023 was -$133M, a 105% decline from 2022.
- HilleVax, Inc. annual Operating Income (Loss) for 2022 was -$65.1M, a 21.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)